Veronica Steri • UCSF Profiles (original) (raw)

  1. Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates. Clin Cancer Res. 2026 Jan 22. Bidkar AP, Bidlingmaier S, Wadhwa A, Mayne E, Raveendran A, Naik S, Xue C, Basak M, Bobba KN, Patiño-Escobar B, Greenland N, Camara Serrano JA, Steri V, Chou J, Wiita A, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Liu B, Flavell RR. PMID: 41569419.
    View in: PubMed Mentions:
  2. Metabolic alterations driven by PFKFB3 upregulation confer resistance to trastuzumab in HER2-positive breast cancer. Biomed Pharmacother. 2026 Jan; 194:118898. Vincken R, Pasco ST, Steri V, Bozal-Basterra L, van IJcken WFJ, Carracedo A, Huylebroeck D, Moasser MM, Ruiz-Sáenz A. PMID: 41496324.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  3. Cellular consequences, citrullination substrates, and antigenicity resulting from wild-type and targeted PAD4 on cell surfaces. bioRxiv. 2026 Jan 06. Kong S, Peters-Clarke TM, Delaveris CS, Phojanakong P, Steri V, Wells JA. PMID: 41542531; PMCID: PMC12803043.
    View in: PubMed Mentions:
  4. Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies. J Immunother Cancer. 2025 Dec 30; 13(12). Izgutdina A, Rashid T, Temple WC, Aminov S, Patiño-Escobar B, Walunj S, Geng H, Takamatsu H, Gil-Alós D, Kang AS, Ramos E, Chen SY, Johnson H, Nix MA, Naik A, Li M, Yuan CM, Wang HW, Sahu S, Larson RC, Carpenter C, Salangsang F, Phojanakong P, Serrano JAC, Tariq I, Zakraoui O, Steri V, Valeri A, Martinez-Lopez J, Maus MV, Parekh S, Verma A, Shah NN, Wiita AP. PMID: 41469141; PMCID: PMC12766774.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  5. Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2. Res Sq. 2025 Oct 29. Wadhwa A, Johnson H, Bobba KN, Bidkar AP, Mayne E, Rampersaud S, Mandal K, Barpanda A, Prudhvi S, Kang AS, Greenland N, Balitzer D, Peter R, Raveendran A, Naik S, Basak M, Kasap C, Werner J, López-Álvarez M, Lee SH, Steri V, Adams JJ, Sidhu SS, Wilson DM, Seo Y, VanBrocklin HF, Logan AC, Wiita AP, Flavell RR. PMID: 41282197; PMCID: PMC12636732.
    View in: PubMed Mentions:
  6. CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer. bioRxiv. 2025 Sep 30. Gini B, Gui P, Wu W, Lucas Kerr D, Tan L, Barbosa D, Olivas V, Allegakoen P, Gomez C, Halliday PR, Elmes S, Steri V, Chakrabarti T, Bivona TG, Blakely CM. PMID: 41256559; PMCID: PMC12622041.
    View in: PubMed Mentions:
  7. Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid Leukemia. bioRxiv. 2025 Sep 21. Kang AS, Johnson H, Lei N, Wong J, Razi N, Izgutdina A, Kasap C, Chilakapati N, Rivera J, Phojanakong P, Serrano JAC, Salangsang F, Steri V, Logan AC, Eyquem J, Huang BJ, Wiita AP. PMID: 41001002; PMCID: PMC12458446.
    View in: PubMed Mentions:
  8. Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. Nat Commun. 2025 Sep 10; 16(1):8215. Chang K, Delavan HM, Yip E, Kasap C, Zhu J, Lodha R, Liao SY, Berman SC, Carretero-Gonzalez A, Basar M, Gokturk Ozcan G, Teo MY, Solit DB, Rosenberg JE, Al-Ahmadie H, Ding CCK, Chan E, Steri V, Porten SP, Koshkin VS, Friedlander TW, Feng FY, Lee JK, Wiita AP, Chu CE, Chou J. PMID: 40931013; PMCID: PMC12423289.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  9. Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2. bioRxiv. 2025 Aug 25. Wadhwa A, Johnson H, Bobba KN, Bidkar AP, Mayne E, Rampersaud S, Mandal K, Barpanda A, Prudhvi S, Kang AS, Greenland N, Balitzer D, Peter R, Raveendran A, Naik S, Basak M, Kasap C, Huebner J, Alvarez ML, Lee S, Steri V, Adams JJ, Sidhu SS, Wilson DM, Seo Y, VanBrocklin HF, Logan AC, Wiita AP, Flavell RR. PMID: 40909732; PMCID: PMC12407801.
    View in: PubMed Mentions:
  10. Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma. bioRxiv. 2025 Aug 23. Chilakapati N, Patiño-Escobar B, Chen EY, Dalal R, de Montagnac J, Johnson H, Kang AS, Akagi N, Ramos E, Phojanakong P, Salangsang F, Zeng Y, Chari A, Chung A, Kumar AD, Martin TG, Wolf JL, Shy BR, Steri V, Karlon WJ, Kortemme T, Barwick BG, Wiita AP. PMID: 40894691; PMCID: PMC12393364.
    View in: PubMed Mentions:
  11. Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells. Blood. 2025 Aug 14; 146(7):819-833. Kasap C, Izgutdina A, Patiño-Escobar B, Kang AS, Chilakapati N, Akagi N, Manoj A, Johnson H, Rashid T, Werner J, Barpanda A, Geng H, Lin YT, Rampersaud S, Gil-Alós D, Sobh A, Dupéré-Richer D, Aleman A, Wicaksono G, Kelii KMK, Dalal R, Ramos E, Vijayanarayanan A, Lakhani K, Salangsang F, Phojanakong P, Camara Serrano JA, Zakraoui O, Tariq I, Chari A, Chung A, Kumar AD, Martin TG, Wolf J, Wong SW, Steri V, Shanmugam M, Boise LH, Kortemme T, Parekh S, Stieglitz E, Licht JD, Karlon WJ, Barwick BG, Wiita AP. PMID: 40359480; PMCID: PMC12783522.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansCells
  12. Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy. Clin Cancer Res. 2025 Jul 15; 31(14):2963-2977. Bidkar AP, Peter R, Wadhwa A, Bobba KN, Bidlingmaier S, Meher N, Chou J, Greenland N, Dasari C, Naik S, Raveendran A, Basak M, Camara Serrano JA, Steri V, Kogan S, Oskowitz A, He J, Wilson DM, Aggarwal R, Sriram R, VanBrocklin HF, Seo Y, Liu B, Flavell RR. PMID: 39945595; PMCID: PMC12260511.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  13. Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies. bioRxiv. 2025 May 15. Izgutdina A, Rashid T, Temple WC, Patiño-Escobar B, Walunj S, Geng H, Takamatsu H, Gil-Alós D, Kang AS, Ramos E, Chen SY, Johnson H, Nix MA, Naik A, Yuan CM, Wang HW, Aminov S, Sahu S, Larson RC, Carpenter C, Salangsang F, Phojanakong P, Serrano JAC, Tariq I, Zakraoui O, Steri V, Valeri A, Martinez-Lopez J, Maus MV, Parekh S, Verma A, Shah NN, Wiita AP. PMID: 40463123; PMCID: PMC12132434.
    View in: PubMed Mentions:
  14. PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer. Mol Cancer Ther. 2025 Jan 02; 24(1):141-151. Meher N, Bidkar AP, Wadhwa A, Bobba KN, Dhrona S, Dasari C, Mu C, Fong COY, Cámara JA, Ali U, Basak M, Bulkley D, Steri V, Fontaine SD, Zhu J, Oskowitz A, Aggarwal RR, Sriram R, Chou J, Wilson DM, Seo Y, Santi DV, Ashley GW, VanBrocklin HF, Flavell RR. PMID: 39331510; PMCID: PMC11694059.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansAnimalsCells
  15. Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer. Cancer Res Commun. 2025 01 01; 5(1):119-127. Sun X, Kumbier K, Gayathri S, Steri V, Wu LF, Altschuler SJ. PMID: 39699269; PMCID: PMC11747858.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimalsCells
  16. Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α. Cell Chem Biol. 2024 Sep 19; 31(9):1729-1739.e9. Delaveris CS, Kong S, Glasgow J, Loudermilk RP, Kirkemo LL, Zhao F, Salangsang F, Phojanakong P, Camara Serrano JA, Steri V, Wells JA. PMID: 39178841; PMCID: PMC11482644.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansAnimalsCells
  17. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma. Blood Neoplasia. 2024 Sep; 1(3):100025. Choudhry P, Kasap C, Patiño-Escobar B, Gugliemini O, Geng H, Sarin V, Kang A, Kishishita A, Rampersaud S, Sarah L, Lin YT, Paranjape N, Ramkumar P, Patton JC, Marcoulis M, Wang D, Phojanakong P, Steri V, Hann B, Barwick BG, Kampmann M, Wiita AP. PMID: 40453054; PMCID: PMC12093323.
    View in: PubMed Mentions:
  18. Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α. bioRxiv. 2024 Mar 20. Delaveris CS, Kong S, Glasgow J, Loudermilk RP, Kirkemo LL, Zhao F, Salangsang F, Phojanakong P, Camara Serrano JA, Steri V, Wells JA. PMID: 38562834; PMCID: PMC10983885.
    View in: PubMed Mentions:
  19. CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clin Cancer Res. 2024 03 01; 30(5):1009-1021. Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, Zhang L, Steri V, Wong SW, Martin TG, Seo Y, Liu B, Wiita AP, Flavell RR. PMID: 38109209; PMCID: PMC10905524.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansAnimalsCells
  20. Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells. bioRxiv. 2024 Feb 28. Kasap C, Izgutdina A, Patiño-Escobar B, Kang A, Chilakapati N, Akagi N, Johnson H, Rashid T, Werner J, Barpanda A, Geng H, Lin YT, Rampersaud S, Gil-Alós D, Sobh A, Dupéré-Richer D, Wicaksono G, Kawehi Kelii KM, Dalal R, Ramos E, Vijayanarayanan A, Salangsang F, Phojanakong P, Serrano JAC, Zakraoui O, Tariq I, Steri V, Shanmugam M, Boise LH, Kortemme T, Stieglitz E, Licht JD, Karlon WJ, Barwick BG, Wiita AP. PMID: 38463958; PMCID: PMC10925123.
    View in: PubMed Mentions:
  21. Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies. J Immunother Cancer. 2023 11 24; 11(11). Temple WC, Nix MA, Naik A, Izgutdina A, Huang BJ, Wicaksono G, Phojanakong P, Serrano JAC, Young EP, Ramos E, Salangsang F, Steri V, Xirenayi S, Hermiston M, Logan AC, Stieglitz E, Wiita AP. PMID: 38007238; PMCID: PMC10680002.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansAnimalsCells
  22. Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML. Cell Rep Med. 2023 11 21; 4(11):101290. Popescu B, Stahlhut C, Tarver TC, Wishner S, Lee BJ, Peretz CAC, Luck C, Phojanakong P, Camara Serrano JA, Hongo H, Rivera JM, Xirenayi S, Chukinas JA, Steri V, Tasian SK, Stieglitz E, Smith CC. PMID: 37992684; PMCID: PMC10694768.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansCells
  23. Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target. Nat Cancer. 2023 11; 4(11):1592-1609. Mandal K, Wicaksono G, Yu C, Adams JJ, Hoopmann MR, Temple WC, Izgutdina A, Escobar BP, Gorelik M, Ihling CH, Nix MA, Naik A, Xie WH, Hübner J, Rollins LA, Reid SM, Ramos E, Kasap C, Steri V, Serrano JAC, Salangsang F, Phojanakong P, McMillan M, Gavallos V, Leavitt AD, Logan AC, Rooney CM, Eyquem J, Sinz A, Huang BJ, Stieglitz E, Smith CC, Moritz RL, Sidhu SS, Huang L, Wiita AP. PMID: 37904046; PMCID: PMC10663162.
    View in: PubMed Mentions: 23 Fields:
    Translation:HumansCells
  24. Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer. Cancer Res. 2023 01 18; 83(2):301-315. Chou J, Egusa EA, Wang S, Badura ML, Lee F, Bidkar AP, Zhu J, Shenoy T, Trepka K, Robinson TM, Steri V, Huang J, Wang Y, Small EJ, Chan E, Stohr BA, Ashworth A, Delafontaine B, Rottey S, Cooke KS, Hashemi Sadraei N, Yu B, Salvati M, Bailis JM, Feng FY, Flavell RR, Aggarwal R. PMID: 36351060; PMCID: PMC10263373.
    View in: PubMed Mentions: 35 Fields:
    Translation:HumansAnimals
  25. Comparison and calibration of dose delivered by137Cs and x-ray irradiators in mice. Phys Med Biol. 2022 11 18; 67(22). Caravaca J, Peter R, Yang J, Gunther C, Antonio Camara Serrano J, Nostrand C, Steri V, Seo Y. PMID: 36317316; PMCID: PMC9933773.
    View in: PubMed Mentions: 1 Fields:
    Translation:Animals
  26. Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins. Nat Biotechnol. 2023 02; 41(2):273-281. Pance K, Gramespacher JA, Byrnes JR, Salangsang F, Serrano JC, Cotton AD, Steri V, Wells JA. PMID: 36138170; PMCID: PMC9931583.
    View in: PubMed Mentions: 82 Fields:
    Translation:Cells
  27. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy. Cancer Cell. 2022 09 12; 40(9):1060-1069.e7. Zhang Z, Rohweder PJ, Ongpipattanakul C, Basu K, Bohn MF, Dugan EJ, Steri V, Hann B, Shokat KM, Craik CS. PMID: 36099883; PMCID: PMC10393267.
    View in: PubMed Mentions: 73 Fields:
    Translation:Humans
  28. Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling. Cell Rep. 2022 09 06; 40(10):111338. Campbell MR, Ruiz-Saenz A, Zhang Y, Peterson E, Steri V, Oeffinger J, Sampang M, Jura N, Moasser MM. PMID: 36070686; PMCID: PMC9484489.
    View in: PubMed Mentions: Fields:
  29. Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma. Cell Chem Biol. 2022 08 18; 29(8):1288-1302.e7. Ferguson ID, Lin YT, Lam C, Shao H, Tharp KM, Hale M, Kasap C, Mariano MC, Kishishita A, Patiño Escobar B, Mandal K, Steri V, Wang D, Phojanakong P, Tuomivaara ST, Hann B, Driessen C, Van Ness B, Gestwicki JE, Wiita AP. PMID: 35853457; PMCID: PMC9434701.
    View in: PubMed Mentions: 11 Fields:
    Translation:HumansCells
  30. Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers. J Clin Invest. 2022 02 15; 132(4). Lim SA, Zhou J, Martinko AJ, Wang YH, Filippova EV, Steri V, Wang D, Remesh SG, Liu J, Hann B, Kossiakoff AA, Evans MJ, Leung KK, Wells JA. PMID: 35166238; PMCID: PMC8843743.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansAnimalsCells
  31. Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers. Cell Rep. 2022 02 01; 38(5):110291. Campbell MR, Ruiz-Saenz A, Peterson E, Agnew C, Ayaz P, Garfinkle S, Littlefield P, Steri V, Oeffinger J, Sampang M, Shan Y, Shaw DE, Jura N, Moasser MM. PMID: 35108525; PMCID: PMC8889928.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansCells
  32. Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling. Cell Rep. 2022 02 01; 38(5):110285. Campbell MR, Ruiz-Saenz A, Zhang Y, Peterson E, Steri V, Oeffinger J, Sampang M, Jura N, Moasser MM. PMID: 35108526; PMCID: PMC8865943.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansAnimalsCells
  33. Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1. Oncogene. 2022 03; 41(11):1536-1549. Melnyk JE, Steri V, Nguyen HG, Hwang YC, Gordan JD, Hann B, Feng FY, Shokat KM. PMID: 35087237; PMCID: PMC8913362.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansCells
  34. The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers. Sci Rep. 2021 04 27; 11(1):9091. Majumder A, Sandhu M, Banerji D, Steri V, Olshen A, Moasser MM. PMID: 33907275; PMCID: PMC8079373.
    View in: PubMed Mentions: 33 Fields:
    Translation:HumansAnimalsCells
  35. Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL. Cancer Discov. 2021 08; 11(8):2032-2049. Nix MA, Mandal K, Geng H, Paranjape N, Lin YT, Rivera JM, Marcoulis M, White KL, Whitman JD, Bapat SP, Parker KR, Ramirez J, Deucher A, Phojanokong P, Steri V, Fattahi F, Hann BC, Satpathy AT, Manglik A, Stieglitz E, Wiita AP. PMID: 33727310; PMCID: PMC8338785.
    View in: PubMed Mentions: 38 Fields:
    Translation:Humans
  36. Transit-Amplifying Cells Coordinate Changes in Intestinal Epithelial Cell-Type Composition. Dev Cell. 2021 02 08; 56(3):356-365.e9. Sanman LE, Chen IW, Bieber JM, Steri V, Trentesaux C, Hann B, Klein OD, Wu LF, Altschuler SJ. PMID: 33484640; PMCID: PMC7917018.
    View in: PubMed Mentions: 36 Fields:
    Translation:HumansAnimalsCells
  37. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells. Bioorg Med Chem. 2020 10 15; 28(20):115712. Melnyk JE, Steri V, Nguyen HG, Hann B, Feng FY, Shokat KM. PMID: 33069070.
    View in: PubMed Mentions: 15 Fields:
    Translation:HumansAnimalsCells
  38. Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation. Proc Natl Acad Sci U S A. 2020 03 17; 117(11):5733-5740. Elledge SK, Tran HL, Christian AH, Steri V, Hann B, Toste FD, Chang CJ, Wells JA. PMID: 32123103; PMCID: PMC7084160.
    View in: PubMed Mentions: 21 Fields:
    Translation:HumansAnimalsCells
  39. KRASG12C inhibition produces a driver-limited state revealing collateral dependencies. Sci Signal. 2019 05 28; 12(583). Lou K, Steri V, Ge AY, Hwang YC, Yogodzinski CH, Shkedi AR, Choi ALM, Mitchell DC, Swaney DL, Hann B, Gordan JD, Shokat KM, Gilbert LA. PMID: 31138768; PMCID: PMC6871662.
    View in: PubMed Mentions: 93 Fields:
    Translation:HumansAnimalsCells
  40. HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3. Cancer Res. 2018 07 01; 78(13):3645-3658. Ruiz-Saenz A, Dreyer C, Campbell MR, Steri V, Gulizia N, Moasser MM. PMID: 29760043; PMCID: PMC6779043.
    View in: PubMed Mentions: 81 Fields:
    Translation:HumansAnimalsCells
  41. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. J Pathol. 2018 06; 245(2):209-221. He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R. PMID: 29603739; PMCID: PMC6737176.
    View in: PubMed Mentions: 66 Fields:
    Translation:HumansAnimalsCells
  42. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017 04 12; 9(385). Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. PMID: 28404866; PMCID: PMC5554432.
    View in: PubMed Mentions: 458 Fields:
    Translation:AnimalsCells
  43. Antagonizing Integrin β3 Increases Immunosuppression in Cancer. Cancer Res. 2016 06 15; 76(12):3484-95. Su X, Esser AK, Amend SR, Xiang J, Xu Y, Ross MH, Fox GC, Kobayashi T, Steri V, Roomp K, Fontana F, Hurchla MA, Knolhoff BL, Meyer MA, Morgan EA, Tomasson JC, Novack JS, Zou W, Faccio R, Novack DV, Robinson SD, Teitelbaum SL, DeNardo DG, Schneider JG, Weilbaecher KN. PMID: 27216180; PMCID: PMC4944657.
    View in: PubMed Mentions: 58 Fields:
    Translation:AnimalsCells
  44. Suppression of β3-integrin in mice triggers a neuropilin-1-dependent change in focal adhesion remodelling that can be targeted to block pathological angiogenesis. Dis Model Mech. 2015 Sep; 8(9):1105-19. Ellison TS, Atkinson SJ, Steri V, Kirkup BM, Preedy ME, Johnson RT, Ruhrberg C, Edwards DR, Schneider JG, Weilbaecher K, Robinson SD. PMID: 26159543; PMCID: PMC4582102.
    View in: PubMed Mentions: 15 Fields:
    Translation:HumansAnimalsCells
  45. Redefining the role(s) of endothelial αvβ3-integrin in angiogenesis. Biochem Soc Trans. 2014 Dec; 42(6):1590-5. Atkinson SJ, Ellison TS, Steri V, Gould E, Robinson SD. PMID: 25399575.
    View in: PubMed Mentions: 23 Fields:
    Translation:Humans
  46. Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice. Circ Res. 2014 Jan 03; 114(1):79-91. Steri V, Ellison TS, Gontarczyk AM, Weilbaecher K, Schneider JG, Edwards D, Fruttiger M, Hodivala-Dilke KM, Robinson SD. PMID: 24103390.
    View in: PubMed Mentions: 23 Fields:
    Translation:AnimalsCells
  47. Fast track biopsy method: a rapid approach to preoperative diagnoses. Pathologica. 2010 Apr; 102(2):41-5. Steri V, Farnedi A, Montinari E, Foschini MP. PMID: 23596755.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  48. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science. 2008 Dec 12; 322(5908):1705-10. Faure-André G, Vargas P, Yuseff MI, Heuzé M, Diaz J, Lankar D, Steri V, Manry J, Hugues S, Vascotto F, Boulanger J, Raposo G, Bono MR, Rosemblatt M, Piel M, Lennon-Duménil AM. PMID: 19074353.
    View in: PubMed Mentions: 129 Fields:
    Translation:AnimalsCells
  49. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood. 2007 Jun 15; 109(12):5371-9. Piccioli D, Tavarini S, Borgogni E, Steri V, Nuti S, Sammicheli C, Bardelli M, Montagna D, Locatelli F, Wack A. PMID: 17332250.
    View in: PubMed Mentions: 96 Fields:
    Translation:HumansCells
  50. AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1245. Abstract 1245: RRx-001 is effective in temozolomide-sensitive and resistant GBM. Steri V., Oronsky B., Scicinski J, Bergers B. View Publication.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs